1. Home
  2. PMCB vs HUBC Comparison

PMCB vs HUBC Comparison

Compare PMCB & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • HUBC
  • Stock Information
  • Founded
  • PMCB 1996
  • HUBC 2017
  • Country
  • PMCB United States
  • HUBC Israel
  • Employees
  • PMCB N/A
  • HUBC N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • HUBC
  • Sector
  • PMCB Health Care
  • HUBC
  • Exchange
  • PMCB Nasdaq
  • HUBC Nasdaq
  • Market Cap
  • PMCB 13.9M
  • HUBC 15.2M
  • IPO Year
  • PMCB N/A
  • HUBC N/A
  • Fundamental
  • Price
  • PMCB $1.62
  • HUBC $0.52
  • Analyst Decision
  • PMCB
  • HUBC
  • Analyst Count
  • PMCB 0
  • HUBC 0
  • Target Price
  • PMCB N/A
  • HUBC N/A
  • AVG Volume (30 Days)
  • PMCB 13.7K
  • HUBC 819.6K
  • Earning Date
  • PMCB 12-24-2024
  • HUBC 12-13-2024
  • Dividend Yield
  • PMCB N/A
  • HUBC N/A
  • EPS Growth
  • PMCB N/A
  • HUBC N/A
  • EPS
  • PMCB 0.74
  • HUBC N/A
  • Revenue
  • PMCB N/A
  • HUBC $33,357,000.00
  • Revenue This Year
  • PMCB N/A
  • HUBC N/A
  • Revenue Next Year
  • PMCB N/A
  • HUBC N/A
  • P/E Ratio
  • PMCB $2.25
  • HUBC N/A
  • Revenue Growth
  • PMCB N/A
  • HUBC N/A
  • 52 Week Low
  • PMCB $1.39
  • HUBC $0.38
  • 52 Week High
  • PMCB $2.58
  • HUBC $2.48
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 45.07
  • HUBC 35.73
  • Support Level
  • PMCB $1.61
  • HUBC $0.38
  • Resistance Level
  • PMCB $1.81
  • HUBC $0.45
  • Average True Range (ATR)
  • PMCB 0.11
  • HUBC 0.05
  • MACD
  • PMCB 0.00
  • HUBC -0.01
  • Stochastic Oscillator
  • PMCB 43.64
  • HUBC 14.14

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: